Kota Kurosaki Selected Research

Thyrotropin-Releasing Hormone Receptors (Thyrotropin Releasing Hormone Receptor)

1/2022

Development of in silico prediction models for drug-induced liver malignant tumors based on the activity of molecular initiating events: Biologically interpretable features.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kota Kurosaki Research Topics

Disease

4	Neoplasms (Cancer) 02/2022 - 01/2021
1	Inflammation (Inflammations) 02/2022
1	Genomic Instability 01/2022
1	Drug-Related Side Effects and Adverse Reactions 12/2021
1	Body Weight (Weight, Body) 12/2021
1	Hiccup (Hiccups) 12/2021
1	Non-alcoholic Fatty Liver Disease 01/2021

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 01/2022 - 01/2021
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 02/2022 - 01/2021
1	azuleneIBA 02/2022
1	AmidesIBA 02/2022
1	Hormones (Hormone)IBA 02/2022
1	Thyrotropin-Releasing Hormone Receptors (Thyrotropin Releasing Hormone Receptor)IBA 01/2022
1	Nicotine FDA Link 12/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2021
1	compound 18IBA 05/2021
1	compound 17IBA 05/2021
1	Acetazolamide (Diamox)FDA LinkGeneric 05/2021